INKON Life Technology Co Ltd - Asset Resilience Ratio
INKON Life Technology Co Ltd (300143) has an Asset Resilience Ratio of 5.73% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See INKON Life Technology Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how INKON Life Technology Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see INKON Life Technology Co Ltd asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down INKON Life Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore INKON Life Technology Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥239.00 Million | 5.73% |
| Total Liquid Assets | CN¥239.00 Million | 5.73% |
Asset Resilience Insights
- Limited Liquidity: INKON Life Technology Co Ltd maintains only 5.73% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
INKON Life Technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare INKON Life Technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Stratec SE
XETRA:SBS |
Medical Devices | 0.29% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
DRTECH Corporation
KQ:214680 |
Medical Devices | 5.18% |
|
Novacyt
PA:ALNOV |
Medical Devices | 0.02% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
Annual Asset Resilience Ratio for INKON Life Technology Co Ltd (2016–2025)
The table below shows the annual Asset Resilience Ratio data for INKON Life Technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 4.75% | CN¥199.00 Million ≈ $29.12 Million |
CN¥4.19 Billion ≈ $613.51 Million |
+3.90pp |
| 2024-12-31 | 0.85% | CN¥30.00 Million ≈ $4.39 Million |
CN¥3.54 Billion ≈ $517.54 Million |
-10.47pp |
| 2020-12-31 | 11.32% | CN¥300.14 Million ≈ $43.92 Million |
CN¥2.65 Billion ≈ $387.89 Million |
+10.96pp |
| 2018-12-31 | 0.36% | CN¥9.43 Million ≈ $1.38 Million |
CN¥2.62 Billion ≈ $383.74 Million |
+0.12pp |
| 2017-12-31 | 0.24% | CN¥6.22 Million ≈ $909.92K |
CN¥2.61 Billion ≈ $382.08 Million |
-19.49pp |
| 2016-12-31 | 19.73% | CN¥500.00 Million ≈ $73.17 Million |
CN¥2.53 Billion ≈ $370.79 Million |
-- |
About INKON Life Technology Co Ltd
INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was … Read more